| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |